INTERNATIONAL PATENT: BLUEPRINT MEDICINES CORPORATION FILES APPLICATION FOR "HIGH-RISK DISEASE FEATURES OF INDOLENT SYSTEMIC MASTOCYTOSIS AND METHODS FOR TREATING"

GENEVA, Aug. 19 -- BLUEPRINT MEDICINES CORPORATION (45 Sidney StreetCambridge, MA 02139) filed a patent application (PCT/US2025/014570) for "HIGH-RISK DISEASE FEATURES OF INDOLENT SYSTEMIC MASTOCYTOSIS AND METHODS FOR TREATING" on Feb 05, 2025. With publication no. WO/2025/170989, the details related to the patent application was published on Aug 14, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): LAMPSON, Benjamin (c/o Blueprint Medicines Corporation45 Sidney StreetCambridge, MA 02139)

Abstract: Improved methods for identifying and treating patients with high-risk disease are disclosed h...